3 Small-Cap Stocks We Steer Clear Of
Repligen Corp RGEN
$102.87
▼ -0.49%
($-0.51)
Open
$104.46
Prev Close
$103.38
Day Range
$102.55 – $107.75
52W Range
$100.99 – $175.77
Market Cap
$5.80B
P/E (TTM)
116.44
Beta
1.06
EPS (TTM)
$0.91
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1986-04-29 |
| Shares Out. | 56,400,000 |
| Website | repligen.com/ ↗ |
| Phone | 13026587581 |
Repligen Corp is a publicly traded company under the ticker symbol RGEN on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
29 analysts (2026-05-01)
📰 Latest News for RGEN
RBC Capital Reinstates Outperform on Repligen, Announces $160 Price Target
5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call
Alger Mid Cap 40 ETF Q1 2026 Portfolio Movers
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Repligen Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Barclays Maintains an “Overweight Rating” on Repligen Corporation (RGEN)
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference